vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and DXP ENTERPRISES INC (DXPE). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $527.4M, roughly 1.8× DXP ENTERPRISES INC). APTARGROUP, INC. runs the higher net margin — 7.7% vs 4.3%, a 3.4% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 12.0%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $34.5M). Over the past eight quarters, DXP ENTERPRISES INC's revenue compounded faster (13.1% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

DXP Enterprises Inc. is a leading industrial distribution firm that provides maintenance, repair, operations (MRO) supplies, fluid handling equipment, pump systems and related technical services. It primarily serves customers in manufacturing, energy, mining, construction sectors, with core market coverage across North America.

ATR vs DXPE — Head-to-Head

Bigger by revenue
ATR
ATR
1.8× larger
ATR
$962.7M
$527.4M
DXPE
Growing faster (revenue YoY)
ATR
ATR
+1.5% gap
ATR
13.5%
12.0%
DXPE
Higher net margin
ATR
ATR
3.4% more per $
ATR
7.7%
4.3%
DXPE
More free cash flow
ATR
ATR
$62.4M more FCF
ATR
$96.9M
$34.5M
DXPE
Faster 2-yr revenue CAGR
DXPE
DXPE
Annualised
DXPE
13.1%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
DXPE
DXPE
Revenue
$962.7M
$527.4M
Net Profit
$74.3M
$22.8M
Gross Margin
31.6%
Operating Margin
11.0%
8.8%
Net Margin
7.7%
4.3%
Revenue YoY
13.5%
12.0%
Net Profit YoY
-26.4%
6.9%
EPS (diluted)
$1.13
$1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
DXPE
DXPE
Q4 25
$962.7M
$527.4M
Q3 25
$961.1M
$513.7M
Q2 25
$966.0M
$498.7M
Q1 25
$887.3M
$476.6M
Q4 24
$848.1M
$470.9M
Q3 24
$909.3M
$472.9M
Q2 24
$910.1M
$445.6M
Q1 24
$915.4M
$412.6M
Net Profit
ATR
ATR
DXPE
DXPE
Q4 25
$74.3M
$22.8M
Q3 25
$127.9M
$21.6M
Q2 25
$111.7M
$23.6M
Q1 25
$78.8M
$20.6M
Q4 24
$100.9M
$21.4M
Q3 24
$100.0M
$21.1M
Q2 24
$90.5M
$16.7M
Q1 24
$83.1M
$11.3M
Gross Margin
ATR
ATR
DXPE
DXPE
Q4 25
31.6%
Q3 25
31.4%
Q2 25
31.6%
Q1 25
31.5%
Q4 24
31.5%
Q3 24
30.9%
Q2 24
30.9%
Q1 24
30.0%
Operating Margin
ATR
ATR
DXPE
DXPE
Q4 25
11.0%
8.8%
Q3 25
14.2%
8.5%
Q2 25
14.9%
9.2%
Q1 25
12.8%
8.5%
Q4 24
14.2%
8.3%
Q3 24
15.2%
8.4%
Q2 24
13.8%
8.4%
Q1 24
12.2%
7.1%
Net Margin
ATR
ATR
DXPE
DXPE
Q4 25
7.7%
4.3%
Q3 25
13.3%
4.2%
Q2 25
11.6%
4.7%
Q1 25
8.9%
4.3%
Q4 24
11.9%
4.5%
Q3 24
11.0%
4.5%
Q2 24
9.9%
3.7%
Q1 24
9.1%
2.7%
EPS (diluted)
ATR
ATR
DXPE
DXPE
Q4 25
$1.13
$1.38
Q3 25
$1.92
$1.31
Q2 25
$1.67
$1.43
Q1 25
$1.17
$1.25
Q4 24
$1.48
$1.28
Q3 24
$1.48
$1.27
Q2 24
$1.34
$1.00
Q1 24
$1.23
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
DXPE
DXPE
Cash + ST InvestmentsLiquidity on hand
$409.5M
$303.8M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$2.7B
$498.4M
Total Assets
$5.3B
$1.7B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
DXPE
DXPE
Q4 25
$409.5M
$303.8M
Q3 25
$264.8M
$123.8M
Q2 25
$169.8M
$112.9M
Q1 25
$136.8M
$114.3M
Q4 24
$226.2M
$148.3M
Q3 24
$327.9M
$35.0M
Q2 24
$223.9M
$49.9M
Q1 24
$201.1M
$139.7M
Total Debt
ATR
ATR
DXPE
DXPE
Q4 25
$1.1B
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
Q2 24
$681.5M
Q1 24
$680.4M
Stockholders' Equity
ATR
ATR
DXPE
DXPE
Q4 25
$2.7B
$498.4M
Q3 25
$2.8B
$488.3M
Q2 25
$2.7B
$468.1M
Q1 25
$2.5B
$444.7M
Q4 24
$2.5B
$422.8M
Q3 24
$2.5B
$402.4M
Q2 24
$2.4B
$384.7M
Q1 24
$2.3B
$375.5M
Total Assets
ATR
ATR
DXPE
DXPE
Q4 25
$5.3B
$1.7B
Q3 25
$5.1B
$1.4B
Q2 25
$4.9B
$1.4B
Q1 25
$4.5B
$1.4B
Q4 24
$4.4B
$1.3B
Q3 24
$4.6B
$1.2B
Q2 24
$4.5B
$1.2B
Q1 24
$4.4B
$1.2B
Debt / Equity
ATR
ATR
DXPE
DXPE
Q4 25
0.43×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
DXPE
DXPE
Operating Cash FlowLast quarter
$183.7M
$37.8M
Free Cash FlowOCF − Capex
$96.9M
$34.5M
FCF MarginFCF / Revenue
10.1%
6.5%
Capex IntensityCapex / Revenue
9.0%
0.6%
Cash ConversionOCF / Net Profit
2.47×
1.65×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$54.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
DXPE
DXPE
Q4 25
$183.7M
$37.8M
Q3 25
$177.6M
$34.9M
Q2 25
$126.0M
$18.6M
Q1 25
$82.7M
$3.0M
Q4 24
$178.2M
$32.1M
Q3 24
$229.3M
$28.3M
Q2 24
$143.6M
$14.7M
Q1 24
$92.3M
$27.0M
Free Cash Flow
ATR
ATR
DXPE
DXPE
Q4 25
$96.9M
$34.5M
Q3 25
$114.3M
$28.1M
Q2 25
$62.5M
$8.3M
Q1 25
$25.9M
$-16.9M
Q4 24
$112.2M
$22.7M
Q3 24
$162.7M
$24.4M
Q2 24
$75.4M
$5.9M
Q1 24
$16.7M
$24.1M
FCF Margin
ATR
ATR
DXPE
DXPE
Q4 25
10.1%
6.5%
Q3 25
11.9%
5.5%
Q2 25
6.5%
1.7%
Q1 25
2.9%
-3.6%
Q4 24
13.2%
4.8%
Q3 24
17.9%
5.2%
Q2 24
8.3%
1.3%
Q1 24
1.8%
5.8%
Capex Intensity
ATR
ATR
DXPE
DXPE
Q4 25
9.0%
0.6%
Q3 25
6.6%
1.3%
Q2 25
6.6%
2.1%
Q1 25
6.4%
4.2%
Q4 24
7.8%
2.0%
Q3 24
7.3%
0.8%
Q2 24
7.5%
2.0%
Q1 24
8.3%
0.7%
Cash Conversion
ATR
ATR
DXPE
DXPE
Q4 25
2.47×
1.65×
Q3 25
1.39×
1.61×
Q2 25
1.13×
0.79×
Q1 25
1.05×
0.14×
Q4 24
1.77×
1.50×
Q3 24
2.29×
1.34×
Q2 24
1.59×
0.88×
Q1 24
1.11×
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

DXPE
DXPE

Service Centers$356.2M68%
Innovative Pumping Solutions$110.0M21%
Supply Chain Services$61.2M12%

Related Comparisons